Science Pool

Clinical proteomics: Supporting Drug Development and Biomarker Discovery

Evotec offers state-of-the-art mass spectrometry-based proteomics solutions to support drug development and biomarker discovery. Our ScreenPep™ platform enables high-throughput, automated plasma and serum proteomics with deep coverage, identifying up to 1,000 proteins from minimal sample volumes. As Europe’s exclusive provider of Proteograph™ technology, we can identify up to 5,000 proteins from human biofluids, enhancing biomarker discovery. Integrated with genomics, transcriptomics, and metabolomics data, Evotec’s proteomics services offer a holistic approach to translational research.

With over 20 years of experience and advanced technologies like timsTOF and Orbitrap, Evotec delivers precise, comprehensive, and scalable proteomics solutions tailored to customer needs.
read out factsheet to learn more about our clinical proteomics and how we can support your drug development

Read it now!